Hans-joachim Eng

Hans Eng is President and CEO of Eng3 Corporation, a Seattle-based company that produces applied biophysics technology for the US and international markets. His 32 years of experience with advanced medical technologies including working for Johnson & Johnson in Europe and the formation, growth, and successful sale of a German medical implant company.

Hans has deep experience in research and development, production, and quality assurance for medical devices. An advanced Mechanical Engineering degree from the University of Applied Sciences, Berlin, combined with his background in material science and proteomics enabled Hans to develop the patented technology that underlies Eng3’s NanoVi products.